ChromaDex (CDXC) 10-Q 13 Aug 15 2015 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Jul. 04, 2015	Aug. 12, 2015
Document And Entity Information
Entity Registrant Name	ChromaDex Corp.
Entity Central Index Key	1,386,570
Document Type	10-Q
Document Period End Date	Jul. 4, 2015
Amendment Flag	false
Current Fiscal Year End Date	--01-02
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	Yes
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		107,444,481
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2,015

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Jul. 04, 2015	Jan. 03, 2015
Current Assets
Cash	$ 5,699,248	$ 3,964,750
Trade receivables, less allowance for doubtful accounts and returns, July 4, 2015 $41,000; January 3, 2015 $38,000	3,099,235	1,906,709
Inventories	3,089,033	3,734,341
Prepaid expenses and other assets	427,248	292,891
Total current assets	12,314,764	9,898,691
Leasehold Improvements and Equipment, net	1,552,250	1,264,660
Deposits	57,560	57,435
Intangible assets, net	298,020	296,061
Total assets	14,222,594	11,516,847
Current Liabilities
Accounts payable	3,094,543	3,451,608
Accrued expenses	1,281,598	853,685
Current maturities of loan payable	148,591	223,358
Current maturities of capital lease obligations	211,932	148,278
Customer deposits and other	229,184	234,435
Deferred rent, current	66,299	69,456
Total current liabilities	5,032,147	4,980,820
Loan payable, less current maturities, net	4,629,023	1,977,113
Capital lease obligations, less current maturities	556,029	423,015
Deferred rent, less current	108,933	137,508
Total Liabilities	10,326,132	7,518,456
Stockholders' Equity
Common stock, $.001 par value; authorized 150,000,000 shares; issued and outstanding July 4, 2015 106,290,803 and January 3, 2015 105,271,058 shares	106,291	105,271
Additional paid-in capital	44,655,200	43,417,442
Accumulated deficit	(40,865,029)	(39,524,322)
Total stockholders' equity	3,896,462	3,998,391
Total liabilities and stockholders' equity	$ 14,222,594	$ 11,516,847

Condensed Consolidated Balance3

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)	Jul. 04, 2015	Jan. 03, 2015
Statement of Financial Position [Abstract]
Trade receivables, less allowance for doubtful accounts and returns	$ 41,000	$ 38,000
Common Stock, Par Value Per Share	$ .001	$ .001
Common Stock, Shares Authorized	150,000,000	150,000,000
Common Stock, Shares, Issued	106,290,803	105,271,058
Common Stock, Shares, Outstanding	106,290,803	105,271,058

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations 3 Months Ended (Unaudited) - USD ($)	3 Months Ended			6 Months Ended
	Jul. 04, 2015	Apr. 04, 2015	Jun. 28, 2014	Jul. 04, 2015	Jun. 28, 2014
Income Statement [Abstract]
Sales, net	$ 6,101,380		$ 3,856,154	$ 11,362,351	$ 6,930,292
Cost of sales	3,630,688		2,457,388	6,964,035	4,546,518
Gross profit	2,470,692		1,398,766	4,398,316	2,383,774
Operating expenses:
Sales and marketing	639,748		571,548	1,225,525	1,036,115
General and administrative	2,015,004		2,468,646	$ 4,262,935	4,806,309
Loss from investment in affiliate					21,543
Operating expenses	2,654,752		3,040,194	$ 5,488,460	5,863,967
Operating loss	(184,060)		(1,641,428)	(1,090,144)	(3,480,193)
Nonoperating income (expense):
Interest income	645		305	1,363	945
Interest expense	(131,777)		(12,019)	(251,926)	(21,910)
Nonoperating expenses	(131,132)		(11,714)	(250,563)	(20,965)
Net loss	$ (315,192)	$ (1,025,515)	$ (1,653,142)	$ (1,340,707)	$ (3,501,158)
Basic and Diluted loss per common share	$ 0		$ (0.02)	$ (.01)	$ (.03)
Basic and Diluted weighted average common shares outstanding	107,409,894		106,185,584	107,304,245	106,130,972

Condensed Consolidated Stateme5

Condensed Consolidated Statements of Operations 6 Months Ended (Unaudited) - USD ($)	3 Months Ended			6 Months Ended
	Jul. 04, 2015	Apr. 04, 2015	Jun. 28, 2014	Jul. 04, 2015	Jun. 28, 2014
Income Statement [Abstract]
Sales, net	$ 6,101,380		$ 3,856,154	$ 11,362,351	$ 6,930,292
Cost of sales	3,630,688		2,457,388	6,964,035	4,546,518
Gross profit	2,470,692		1,398,766	4,398,316	2,383,774
Operating expenses:
Sales and marketing	639,748		571,548	1,225,525	1,036,115
General and administrative	2,015,004		2,468,646	$ 4,262,935	4,806,309
Loss from investment in affiliate					21,543
Operating expenses	2,654,752		3,040,194	$ 5,488,460	5,863,967
Operating loss	(184,060)		(1,641,428)	(1,090,144)	(3,480,193)
Nonoperating income (expense):
Interest income	645		305	1,363	945
Interest expense	(131,777)		(12,019)	(251,926)	(21,910)
Nonoperating expenses	(131,132)		(11,714)	(250,563)	(20,965)
Net loss	$ (315,192)	$ (1,025,515)	$ (1,653,142)	$ (1,340,707)	$ (3,501,158)
Basic and Diluted loss per common share	$ 0		$ (0.02)	$ (.01)	$ (.03)
Basic and Diluted weighted average common shares outstanding	107,409,894		106,185,584	107,304,245	106,130,972

Condensed Consolidated Stateme6

Condensed Consolidated Statement of Stockholders' Equity (Unaudited) - USD ($)	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Total
Beginning Balance, Shares at Jan. 03, 2015	105,270,058
Beginning Balance, Amount at Jan. 03, 2015	$ 105,271	$ 43,417,442	$ (39,524,322)	$ 3,998,391
Share-based compensation, Shares	210,000
Share-based compensation, Amount	$ 210	715,699		715,909
Vested restricted stock, shares	506,000
Vested restricted stock, Amount	$ 506	$ (506)
Net loss			$ (1,025,515)	(1,025,515)
Ending Balance, Shares at Apr. 04, 2015	105,987,058
Ending Balance, Amount at Apr. 04, 2015	$ 105,987	$ 44,132,635	(40,549,837)	3,688,785
Beginning Balance, Shares at Jan. 03, 2015	105,270,058
Beginning Balance, Amount at Jan. 03, 2015	$ 105,271	43,417,442	(39,524,322)	$ 3,998,391
Exercise of stock options, Shares
Net loss				$ (1,340,707)
Ending Balance, Shares at Jul. 04, 2015	106,290,803
Ending Balance, Amount at Jul. 04, 2015	$ 106,291	44,655,200	(40,865,029)	3,896,462
Beginning Balance, Shares at Apr. 04, 2015	105,987,058
Beginning Balance, Amount at Apr. 04, 2015	$ 105,987	44,132,635	$ (40,549,837)	3,688,785
Exercise of stock options, Shares	22,745
Exercise of stock options, Amount	$ 23	15,578		15,601
Share-based compensation, Shares	125,000
Share-based compensation, Amount	$ 125	507,143		507,268
Vested restricted stock, shares	156,000
Vested restricted stock, Amount	$ 156	$ (156)
Net loss			$ (315,192)	(315,192)
Ending Balance, Shares at Jul. 04, 2015	106,290,803
Ending Balance, Amount at Jul. 04, 2015	$ 106,291	$ 44,655,200	$ (40,865,029)	$ 3,896,462

Condensed Consolidated Stateme7

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jul. 04, 2015	Jun. 28, 2014
Cash Flows From Operating Activities
Net loss	$ (1,340,707)	$ (3,501,158)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation of leasehold improvements and equipment	137,279	106,832
Amortization of intangibles	20,541	15,713
Share-based compensation expense	1,223,177	2,036,269
Allowance for doubtful trade receivables	$ 3,365	16,167
Gain on exchange of equipment		$ (17,301)
Loss from disposal of equipment	$ 18,226
Loss from investment in affiliate		$ 21,543
Non-cash financing costs	$ 92,143
Changes in operating assets and liabilities:
Trade receivables	$ (1,195,891)	$ (1,298,535)
Other receivable		215,000
Inventories	$ 645,308	(668,903)
Prepaid expenses and other assets	(134,482)	(96,032)
Accounts payable	(357,065)	1,445,848
Accrued expenses	427,913	81,701
Customer deposits and other	(5,251)	(282,774)
Deferred rent	(31,732)	(22,524)
Net cash used in operating activities	(497,176)	(1,948,154)
Cash Flows From Investing Activities
Purchases of leasehold improvements and equipment	(139,162)	(23,370)
Purchases of intangible assets	$ (22,500)	(70,000)
Proceeds from sale of equipment		1,356
Proceeds from investment in affiliate		1,092,500
Net cash provided by (used in) investing activities	$ (161,662)	1,000,486
Cash Flows From Financing Activities
Proceeds from exercise of stock options	15,601	$ 45,095
Proceeds from loan payable	2,500,000
Payment of debt issuance cost	(15,000)
Principal payments on capital leases	(107,265)	$ (78,136)
Net cash provided by (used in) financing activities	2,393,336	(33,041)
Net increase (decrease) in cash	1,734,498	(980,709)
Cash Beginning of Period	3,964,750	2,261,336
Cash Ending of Period	5,699,248	1,280,627
Supplemental Disclosures of Cash Flow Information
Cash payments for interest	159,783	21,910
Supplemental Schedule of Noncash Investing Activity
Capital lease obligation incurred for the purchase of equipment	$ 303,933	222,629
Retirement of fully depreciated equipment		56,110
Supplemental Schedule of Noncash Operating Activity
Stock issued to settle outstanding payable balance		128,494
Supplemental Schedule of Noncash Share-based Compensation
Changes in prepaid expenses associated with share-based compensation		$ 55,631

Interim Financial Statements

Interim Financial Statements	6 Months Ended
	Jul. 04, 2015
Interim Financial Statements
Note 1. Interim Financial Statements	The accompanying financial statements of ChromaDex Corporation (the “Company”) and its wholly owned subsidiaries, ChromaDex, Inc., ChromaDex Analytics, Inc. and Spherix Consulting, Inc. include all adjustments, consisting of normal recurring adjustments and accruals, that, in the opinion of the management of the Company, are necessary for a fair presentation of the Company’s financial position as of July 4, 2015 and results of operations and cash flows for the three and six months ended July 4, 2015 and June 28, 2014. These unaudited interim financial statements should be read in conjunction with the Company’s audited financial statements and the notes thereto for the year ended January 3, 2015 appearing in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (the “Commission”) on March 19, 2015. Operating results for the six months ended July 4, 2015 are not necessarily indicative of the results to be achieved for the full year ending on January 2, 2016. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates. The balance sheet at January 3, 2015 has been derived from the audited financial statements at that date, but does not include all of the information and footnotes required by GAAP for complete financial statements.

Nature of Business and Liquidit

Nature of Business and Liquidity	6 Months Ended
	Jul. 04, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Note 2. Nature of Business and Liquidity	Nature of business Liquidity While we anticipate that our current cash and cash equivalents on hand and cash generated from operations will be sufficient meet our projected operating plans through at least December 31, 2016, we may require additional funds, either through additional equity or debt financings or collaborative agreements or from other sources. We have no commitments to obtain such additional financing, and we may not be able to obtain any such additional financing on terms favorable to us, or at all. If adequate financing is not available, the Company will further delay, postpone or terminate product and service expansion and curtail certain selling, general and administrative operations. The inability to raise additional financing may have a material adverse effect on the future performance of the Company.

Significant Accounting Policies

Significant Accounting Policies	6 Months Ended
	Jul. 04, 2015
Accounting Policies [Abstract]
Note 3. Significant Accounting Policies	Basis of presentation Changes in accounting principle: The Company early adopted the amendments in this ASU effective as of April 4, 2015. As of July 4, 2015 and January 3, 2015, the Company had unamortized debt issuance costs of $85,161 and $91,361, respectively. The Company had previously presented the debt issuance costs as other noncurrent assets in its consolidated balance sheet as of January 3, 2015 in the Company’s Annual Report on Form 10-K filed with the Commission on March 19, 2015. The early adoption has resulted in adjustments to the Company’s consolidated balance sheet as of January 3, 2015, by reclassifying the debt issuance costs as a direct deduction from the carrying amount of the debt liability. Below are the effects of the change on the consolidated balance sheet as of January 3, 2015. ChromaDex Corporation and Subsidiaries Condensed Consolidated Balance Sheet January 3, 2015 Previously Reported Adjustments As Adjusted Assets Current Assets $ 9,898,691 $ - $ 9,898,691 Leasehold Improvements and Equipment, net 1,264,660 - 1,264,660 Other Noncurrent Assets 444,857 (91,361 ) 353,496 Total assets $ 11,608,208 $ (91,361 ) $ 11,516,847 Liabilities and Stockholders' Equity Current Liabilities $ 4,980,820 $ - $ 4,980,820 Loan payable, less current maturities, net 2,068,474 (91,361 ) 1,977,113 Capital lease obligations, less current maturities 423,015 - 423,015 Deferred rent, less current 137,508 - 137,508 Total liabilities 7,609,817 (91,361 ) 7,518,456 Total stockholders' equity 3,998,391 - 3,998,391 Total liabilities and stockholders' equity $ 11,608,208 $ (91,361 ) $ 11,516,847 Inventories July 4, 2015 January 3, 2015 Natural product fine chemicals $ 1,695,315 $ 1,760,305 Bulk ingredients 1,957,718 2,298,036 3,653,033 4,058,341 Less valuation allowance 564,000 324,000 $ 3,089,033 $ 3,734,341

Loss Per Share Applicable to Co

Loss Per Share Applicable to Common Stockholders	6 Months Ended
	Jul. 04, 2015
Loss Per Share Applicable To Common Stockholders
Note 4. Loss Per Share Applicable to Common Stockholders	The following table sets forth the computations of loss per share amounts applicable to common stockholders for the three and six months ended July 4, 2015 and June 28, 2014: Three Months Ended Six Months Ended July 4, 2015 June 28, 2014 July 4, 2015 June 28, 2014 Net loss $ (315,192 ) $ (1,653,142 ) $ (1,340,707 ) $ (3,501,158 ) Basic and diluted loss per common share $ (0.00 ) $ (0.02 ) $ (0.01 ) $ (0.03 ) Weighted average common shares outstanding (1): 107,409,894 106,185,584 107,304,245 106,130,972 Potentially dilutive securities (2): Stock options 14,120,114 14,686,002 14,120,114 14,686,002 Warrants 469,020 - 469,020 - Convertible Debt 773,395 - 773,395 - (1) Includes 1,230,484 and 1,600,879 weighted average nonvested shares of restricted stock for the three months ended July 4, 2015 and June 28, 2014, respectively, and 1,392,285 and 1,571,483 weighted average nonvested shares of restricted stock for the six months ended July 4, 2015 and June 28, 2014, respectively, which are participating securities (2) Excluded from the computation of loss per share as their impact is antidilutive.

Leasehold Improvements and Equi

Leasehold Improvements and Equipment	6 Months Ended
	Jul. 04, 2015
Leasehold Improvements And Equipment
Note 5. Leasehold Improvements and Equipment	Leasehold improvements and equipment consisted of the following: July 4, 2015 January 3, 2015 Laboratory equipment $ 3,530,714 $ 3,151,748 Leasehold improvements 503,343 495,240 Computer equipment 347,786 329,737 Furniture and fixtures 13,039 13,039 Office equipment 21,547 7,877 Construction in progress 18,948 68,141 4,435,377 4,065,782 Less accumulated depreciation 2,883,127 2,801,122 $ 1,552,250 $ 1,264,660 Depreciation expense on leasehold improvements and equipment included in the consolidated statement of operations for the six months ended July 4, 2015 and June 28, 2014 was approximately $137,000 and $107,000, respectively.

Loan Payable

Loan Payable	6 Months Ended
	Jul. 04, 2015
Debt Disclosure [Abstract]
Note 6. Loan Payable	On June 17, 2015, the Company and Hercules Technology II, L.P entered into Amendment No. 1 (the “Amendment”) to the Loan and Security Agreement entered into by the parties on September 29, 2014 (the “Agreement”). The terms of the Agreement provided the Company with access to a term loan of up to $5 million. The first $2.5 million of the term loan was funded at closing. The remaining $2.5 million of the term loan was to be drawn down in part or in full at our option at any time but no later than July 31, 2015. The first advance and second advance, if any, were to be repaid in equal monthly installments through the loan’s maturity on April 1, 2018, following an initial interest-only period that was to conclude on October 31, 2015. Pursuant to the Amendment, the parties agreed that the interest only period shall be extended to March 31, 2016, provided however that if the Company’s consolidated revenue is equal to or greater than $11.5 million for the six months ending December 31, 2015, then the interest-only period shall be extended to June 30, 2016. The maturity date remains unchanged at April 1, 2018 and any remaining principal balance of the loan and all unpaid interest shall be due on the maturity date. The Amendment became effective on June 18, 2015 upon the funding of the full amount of the $2.5 million second advance and payment of a nonrenewable facility fee of $15,000 to the Agent. The second advance of $2.5 million is treated as if the Company entered into a separate loan. The facility fee of $15,000 is treated as debt issuance costs and are being amortized as interest expense using the effective interest method over the term of the loan. There is also additional $93,750 end of term charge the Company will pay, which is 3.75% of the $2.5 million drawn. The end of term charge is being accrued as additional interest expense using the effective interest rate method over the term of the loan. The Company determined that the amended terms of the first advance of $2.5 million on September 29, 2014 were not substantially different from the original terms. The Company therefore did not apply debt extinguishment treatment, but rather accounted for prospectively as yield adjustments, based on the revised terms. Loan payable as of July 4, 2015 consists of the following: Principal amount payable for following years ending December 2015 $ - 2016 905,393 2017 1,945,650 2018 2,148,957 Total principal payments 5,000,000 Accrued end of term charge 31,410 Total loan payable 5,031,410 Less unamortized debt issuance costs and debt discount 253,796 Less current portion 148,591 Loan payable – long term $ 4,629,023 The total interest expenses related to the term loan, including cash interest payments, the amortizations of debt issuance costs and debt discount, and the accrual of the end of term charge were approximately $115,000 and $221,000 for the three and six months ended July 4, 2015. For the three and six months ended June 28, 2014, the Company did not have any interest expense related to loan payable as the Company did not have any outstanding balance.

Share-Based Compensation

Share-Based Compensation	6 Months Ended
	Jul. 04, 2015
Share-based Compensation
Note 7. Share-Based Compensation	7A. Employee Share-Based Compensation Stock Option Plans Service Period The majority of options granted by the Company feature service conditions. Accordingly, these options vest ratably over specified The following table summarizes our stock option activity during Weighted Average Remaining Aggregate Number of Exercise Contractual Intrinsic Shares Price Term Value Outstanding at January 3, 2015 12,723,601 $ 1.13 7.00 Options Granted 225,000 1.28 10.00 Options Classification from Employee to Non-Employee (1,202,762 ) 0.91 Options Exercised (22,745 ) 0.69 Options Forfeited (56,193 ) 1.18 Outstanding at July 4, 2015 11,666,901 $ 1.16 6.46 $ 2,231,000 Exercisable at July 4, 2015 9,508,077 $ 1.16 6.01 $ 1,862,000 The aggregate intrinsic values in the table Certain employees who were previously classified as employees under the share-based compensation plan have been reclassified to non-employees during the six months ended July 4, 2015 as they became consultants. There was no impact on accounting as the options were fully vested. The fair value of the Company’s stock options was estimated at the date of grant using the Black-Scholes option pricing model. The table below outlines the weighted average assumptions for options granted to employees during the six months ended July 4, 2015. Six Months Ended July 4, 2015 Expected volatility 75 % Expected dividends 0.00 % Expected term 6.0 years Risk-free rate 1.72 % The weighted average grant date fair value of options granted during the six months ended July 4, 2015 was $0.85. As of July 4, 2015, there was approximately $1,173,000 of total unrecognized compensation expense expected to be recognized over a weighted average period of 2.45 years. Stock Award On April 16, 2015, the Company awarded 125,000 shares of the Company’s common stock that were fully vested and non-forfeitable to Mark Germain, who resigned from the Board. These shares were granted as compensation for his services as a director of the Company through April 16, 2015. The fair value of the award, which amounted to approximately $154,000 was based on the trading price of the Company’s stock on the date of grant. The expense related to this stock award was immediately recognized. Restricted Stock Restricted stock awards granted by the Company to employees have vesting conditions that are unique to each award. The following table summarizes activity of restricted stock awards granted to employees at July 4, 2015 and changes during the six months then ended: Weighted Average Award-Date Shares Fair Value Unvested shares at January 3, 2015 1,590,000 $ 1.18 Granted - - Vested (510,000 ) 1.41 Forfeited - - Unvested shares at July 4, 2015 1,080,000 $ 1.08 Expected to Vest as of July 4, 2015 1,080,000 $ 1.08 On February 25, 2015, former members of the Company’s Board of Directors (the “Board”), Michael Brauser and Barry Honig, resigned from the Board. The Board made a resolution that 250,000 shares of unvested restricted stock held by Mr. Brauser and 250,000 shares of unvested restricted stock held by Mr. Honig are immediately vested on the date of resignation. The expense for these vested restricted stock was recognized during the fiscal year ended January 3, 2015. On April 16, 2015, a former member of the Board, Mark Germain, resigned from the Board. The Board made a resolution that 10,000 shares of unvested restricted stock held by Mr. Germain are immediately vested on the date of resignation. The expense for these vested restricted stock was recognized during the fiscal year ended January 3, 2015. Employee Option, Stock and Restricted Stock Compensation The Company recognized compensation expense of approximately $442,000 and $820,000 in general and administrative expenses in the statement of operations for the three and six months ended July 4, 2015, respectively, and approximately $1,021,000 and $1,970,000 for the three and six months ended June 28, 2014, respectively. 7B. Non-Employee Share-Based Compensation Stock Option Plans The following table summarizes activity of stock options granted to non-employees at July 4, 2015 and changes during the six months then ended: Weighted Average Remaining Aggregate Number of Exercise Contractual Intrinsic Shares Price Term Value Outstanding at January 3, 2015 1,050,451 $ 1.35 5.46 Options Granted - - Options Classification from Employee to Non-Employee 1,202,762 0.91 Options Exercised - - Options Forfeited - - Outstanding at July 4, 2015 2,253,213 $ 1.12 6.28 $ 473,000 Exercisable at July 4, 2015 2,196,963 $ 1.11 6.21 $ 473,000 The aggregate intrinsic values in the table above are based on the Company’s closing stock price of $1.22 on the last day of business for the period ended July 4, 2015. As of July 4, 2015, there was approximately $38,000 of total unrecognized compensation expense expected to be recognized over a weighted average period of 1.19 years. Stock and Restricted Stock Awards Restricted stock awards granted by the Company to non-employees generally feature time vesting service conditions, specified in the respective service agreements. Restricted stock awards issued to non-employees are accounted for at current fair value through the vesting period. On January 27, 2015, the Company awarded 350,000 shares of the Company’s common stock to non-employees. 210,000 of these shares were treated as stock awards as the shares vested immediately on the date of award, and the remaining 140,000 shares, which were initially treated as unvested restricted stock, vested on May 28, 2015. The fair values of the awards, which totaled approximately $350,000, were measured based on the trading prices of the Company’s stock on the date of award and the date vested. The expense related to these stock awards were fully recognized during the six-month period ended July 4, 2015. In addition, 12,000 shares of restricted stock that were granted to a certain non-employee during the fiscal year ended January 3, 2015 became vested during the six-month period ended July 4, 2015. The fair value of these vested restricted shares was approximately $15,000, which represents the market value of the Company’s common stock on respective vesting dates charged to expense. The following table summarizes activity of restricted stock awards issued to non-employees at July 4, 2015 and changes during the six months then ended: Weighted Average Shares Fair Value Unvested shares at January 3, 2015 76,000 $ 0.90 Granted 140,000 0.86 Vested (152,000 ) 1.21 Forfeited - - Unvested shares expected to vest at July 4, 2015 64,000 $ 1.22 As of July 4, 2015, there was approximately $78,000 of total unrecognized compensation expense related to the restricted stock award to a non-employee. That cost is expected to be recognized over a period of 2.7 years as of July 4, 2015. Non-Employee Option, Stock and Restricted Stock Compensation The Company recognized share-based compensation expense of approximately $65,000 and $403,000 in general and administrative expenses in the statement of operations for the three and six months ended July 4, 2015 and approximately $16,000 and $66,000 for the three and six months ended June 28, 2014, respectively.

Business Segments

Business Segments	6 Months Ended
	Jul. 04, 2015
Business Segments
Note 8. Business Segments	The Company has following three reportable segments. · Ingredients segment develops and commercializes proprietary-based ingredient technologies and supplies these ingredients to the manufacturers of consumer products in various industries including the nutritional supplement, food and beverage and animal health industries. · Core standards, and contract services segment includes supply of phytochemical reference standards, which are small quantities of plant-based compounds typically used to research an array of potential attributes, reference materials, and related contract services. · Scientific and regulatory consulting segment which consist of providing scientific and regulatory consulting to the clients in the food, supplement and pharmaceutical industries to manage potential health and regulatory risks. The “Other” classification includes corporate items not allocated by the Company to each reportable segment. Further, there are no intersegment sales that require elimination. The Company evaluates performance and allocates resources based on reviewing gross margin by reportable segment. Three months ended July 4, 2015 Ingredients segment Core Standards and Contract Services segment Scientific and Regulatory Consulting segment Other Total Net sales $ 3,411,636 $ 2,371,477 $ 318,267 $ - $ 6,101,380 Cost of sales 1,869,205 1,635,294 126,189 - 3,630,688 Gross profit 1,542,431 736,183 192,078 - 2,470,692 Operating expenses: Sales and marketing 298,281 336,392 5,075 - 639,748 General and administrative - - - 2,015,004 2,015,004 Operating expenses 298,281 336,392 5,075 2,015,004 2,654,752 Operating income (loss) $ 1,244,150 $ 399,791 $ 187,003 $ (2,015,004 ) $ (184,060 ) Three months ended June 28, 2014 Ingredients segment Core Standards and Contract Services segment Scientific and Regulatory Consulting segment Other Total Net sales $ 1,721,872 $ 1,856,950 $ 277,332 $ - $ 3,856,154 Cost of sales 1,043,538 1,295,530 118,320 - 2,457,388 Gross profit 678,334 561,420 159,012 - 1,398,766 Operating expenses: Sales and marketing 310,386 221,797 39,365 - 571,548 General and administrative - - - 2,468,646 2,468,646 Operating expenses 310,386 221,797 39,365 2,468,646 3,040,194 Operating income (loss) $ 367,948 $ 339,623 $ 119,647 $ (2,468,646 ) $ (1,641,428 ) Six months ended July 4, 2015 Ingredients segment Core Standards and Contract Services segment Scientific and Regulatory Consulting segment Other Total Net sales $ 6,091,977 $ 4,671,520 $ 598,854 $ - $ 11,362,351 Cost of sales 3,472,381 3,209,078 282,576 - 6,964,035 Gross profit 2,619,596 1,462,442 316,278 - 4,398,316 Operating expenses: Sales and marketing 572,905 647,336 5,284 - 1,225,525 General and administrative - - - 4,262,935 4,262,935 Operating expenses 572,905 647,336 5,284 4,262,935 5,488,460 Operating income (loss) $ 2,046,691 $ 815,106 $ 310,994 $ (4,262,935 ) $ (1,090,144 ) Six months ended June 28, 2014 Ingredients segment Core Standards and Contract Services segment Scientific and Regulatory Consulting segment Other Total Net sales $ 2,858,181 $ 3,592,833 $ 479,278 $ - $ 6,930,292 Cost of sales 1,761,715 2,489,165 295,638 - 4,546,518 Gross profit 1,096,466 1,103,668 183,640 - 2,383,774 Operating expenses: Sales and marketing 550,346 434,572 51,197 - 1,036,115 General and administrative - - - 4,806,309 4,806,309 Loss from investment in affiliate - - - 21,543 21,543 Operating expenses 550,346 434,572 51,197 4,827,852 5,863,967 Operating income (loss) $ 546,120 $ 669,096 $ 132,443 $ (4,827,852 ) $ (3,480,193 ) -13- Core Standards and Scientific and At July 4, 2015 Ingredients Contract Services Regulatory Consulting segment segment segment Other Total Total assets $ 4,275,827 $ 3,406,936 $ 185,357 $ 6,354,474 $ 14,222,594 Core Standards and Scientific and At January 3, 2015 Ingredients Contract Services Regulatory Consulting segment segment segment Other Total Total assets $ 3,757,073 $ 3,220,518 $ 105,711 $ 4,433,545 $ 11,516,847

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jul. 04, 2015
Commitments and Contingencies Disclosure [Abstract]
Note 9. Commitments and Contingencies	Capitalized Lease Obligations On January 31, 2015, the Company entered into a financing transaction to purchase laboratory equipment. Under the lease terms, the Company will make monthly lease payments, including interest, of approximately $7,000 for 48 months, for a total payment of approximately $356,000. The Company has recorded a capital lease of approximately $304,000. The equipment will be utilized in our core standards and contract services segment. Subsequent to July 4, 2015, the Company entered into a financing transaction to purchase laboratory equipment. Under the lease terms, the Company will make monthly lease payments, including interest, of approximately $5,000 for 60 months, for a total payment of approximately $276,000. The Company will record a capital lease of approximately $243,000. The equipment will be utilized in our core standards and contract services segment.

Subsequent Events

Subsequent Events	6 Months Ended
	Jul. 04, 2015
Subsequent Events [Abstract]
Note 10. Subsequent Events	On July 6, 2015, the Board of Directors (the “Board”) granted approximately 917,000 and 675,000 stock options to the Company’s employees and members of the Board, respectively, with an exercise price of $1.22 per share. On July 9, 2015, the Board appointed Robert Fried to serve as a member of the Board. Also on July 9, 2015, Glenn Halpryn resigned from the Board. On July 30, 2015, the Board awarded 200,000 stock options to Robert Fried with an exercise price of $1.10 per share.

Significant Accounting Polici18

Significant Accounting Policies (Policy)	6 Months Ended
	Jul. 04, 2015
Accounting Policies [Abstract]
Basis of presentation	Basis of presentation
Changes in accounting principle	Changes in accounting principle: The Company early adopted the amendments in this ASU effective as of April 4, 2015. As of July 4, 2015 and January 3, 2015, the Company had unamortized debt issuance costs of $85,161 and $91,361, respectively. The Company had previously presented the debt issuance costs as other noncurrent assets in its consolidated balance sheet as of January 3, 2015 in the Company’s Annual Report on Form 10-K filed with the Commission on March 19, 2015. The early adoption has resulted in adjustments to the Company’s consolidated balance sheet as of January 3, 2015, by reclassifying the debt issuance costs as a direct deduction from the carrying amount of the debt liability. Below are the effects of the change on the consolidated balance sheet as of January 3, 2015. ChromaDex Corporation and Subsidiaries Condensed Consolidated Balance Sheet January 3, 2015 Previously Reported Adjustments As Adjusted Assets Current Assets $ 9,898,691 $ - $ 9,898,691 Leasehold Improvements and Equipment, net 1,264,660 - 1,264,660 Other Noncurrent Assets 444,857 (91,361 ) 353,496 Total assets $ 11,608,208 $ (91,361 ) $ 11,516,847 Liabilities and Stockholders' Equity Current Liabilities $ 4,980,820 $ - $ 4,980,820 Loan payable, less current maturities, net 2,068,474 (91,361 ) 1,977,113 Capital lease obligations, less current maturities 423,015 - 423,015 Deferred rent, less current 137,508 - 137,508 Total liabilities 7,609,817 (91,361 ) 7,518,456 Total stockholders' equity 3,998,391 - 3,998,391 Total liabilities and stockholders' equity $ 11,608,208 $ (91,361 ) $ 11,516,847
Inventories	Inventories July 4, 2015 January 3, 2015 Natural product fine chemicals $ 1,695,315 $ 1,760,305 Bulk ingredients 1,957,718 2,298,036 3,653,033 4,058,341 Less valuation allowance 564,000 324,000 $ 3,089,033 $ 3,734,341

Significant Accounting Polici19

Significant Accounting Policies (Tables)	6 Months Ended
	Jul. 04, 2015
Accounting Policies [Abstract]
Restatement	ChromaDex Corporation and Subsidiaries Condensed Consolidated Balance Sheet January 3, 2015 Previously Reported Adjustments As Adjusted Assets Current Assets $ 9,898,691 $ - $ 9,898,691 Leasehold Improvements and Equipment, net 1,264,660 - 1,264,660 Other Noncurrent Assets 444,857 (91,361 ) 353,496 Total assets $ 11,608,208 $ (91,361 ) $ 11,516,847 Liabilities and Stockholders' Equity Current Liabilities $ 4,980,820 $ - $ 4,980,820 Loan payable, less current maturities, net 2,068,474 (91,361 ) 1,977,113 Capital lease obligations, less current maturities 423,015 - 423,015 Deferred rent, less current 137,508 - 137,508 Total liabilities 7,609,817 (91,361 ) 7,518,456 Total stockholders' equity 3,998,391 - 3,998,391 Total liabilities and stockholders' equity $ 11,608,208 $ (91,361 ) $ 11,516,847
Inventories	July 4, 2015 January 3, 2015 Natural product fine chemicals $ 1,695,315 $ 1,760,305 Bulk ingredients 1,957,718 2,298,036 3,653,033 4,058,341 Less valuation allowance 564,000 324,000 $ 3,089,033 $ 3,734,341

Loss Per Share Applicable to 20

Loss Per Share Applicable to Common Stockholders (Tables)	6 Months Ended
	Jul. 04, 2015
Loss Per Share Applicable To Common Stockholders Tables
Loss per share amounts applicable to common stockholders	Three Months Ended Six Months Ended July 4, 2015 June 28, 2014 July 4, 2015 June 28, 2014 Net loss $ (315,192 ) $ (1,653,142 ) $ (1,340,707 ) $ (3,501,158 ) Basic and diluted loss per common share $ (0.00 ) $ (0.02 ) $ (0.01 ) $ (0.03 ) Weighted average common shares outstanding (1): 107,409,894 106,185,584 107,304,245 106,130,972 Potentially dilutive securities (2): Stock options 14,120,114 14,686,002 14,120,114 14,686,002 Warrants 469,020 - 469,020 - Convertible Debt 773,395 - 773,395 - (1) Includes 1,230,484 and 1,600,879 weighted average nonvested shares of restricted stock for the three months ended July 4, 2015 and June 28, 2014, respectively, and 1,392,285 and 1,571,483 weighted average nonvested shares of restricted stock for the six months ended July 4, 2015 and June 28, 2014, respectively, which are participating securities (2) Excluded from the computation of loss per share as their impact is antidilutive.

Leasehold Improvements and Eq21

Leasehold Improvements and Equipment (Tables)	6 Months Ended
	Jul. 04, 2015
Leasehold Improvements And Equipment
Leasehold improvements and equipment	July 4, 2015 January 3, 2015 Laboratory equipment $ 3,530,714 $ 3,151,748 Leasehold improvements 503,343 495,240 Computer equipment 347,786 329,737 Furniture and fixtures 13,039 13,039 Office equipment 21,547 7,877 Construction in progress 18,948 68,141 4,435,377 4,065,782 Less accumulated depreciation 2,883,127 2,801,122 $ 1,552,250 $ 1,264,660

Loan Payable (Tables)

Loan Payable (Tables)	6 Months Ended
	Jul. 04, 2015
Debt Disclosure [Abstract]
Loan payable	Principal amount payable for following years ending December 2015 $ - 2016 905,393 2017 1,945,650 2018 2,148,957 Total principal payments 5,000,000 Accrued end of term charge 31,410 Total loan payable 5,031,410 Less unamortized debt issuance costs and debt discount 253,796 Less current portion 148,591 Loan payable – long term $ 4,629,023

Share-Based Compensation (Table

Share-Based Compensation (Tables)	6 Months Ended
	Jul. 04, 2015
Share-based Compensation Tables
Service Period Based Stock Options	Weighted Average Remaining Aggregate Number of Exercise Contractual Intrinsic Shares Price Term Value Outstanding at January 3, 2015 12,723,601 $ 1.13 7.00 Options Granted 225,000 1.28 10.00 Options Classification from Employee to Non-Employee (1,202,762 ) 0.91 Options Exercised (22,745 ) 0.69 Options Forfeited (56,193 ) 1.18 Outstanding at July 4, 2015 11,666,901 $ 1.16 6.46 $ 2,231,000 Exercisable at July 4, 2015 9,508,077 $ 1.16 6.01 $ 1,862,000
Weighted average assumptions of stock options granted	Six Months Ended July 4, 2015 Expected volatility 75 % Expected dividends 0.00 % Expected term 6.0 years Risk-free rate 1.72 %
Restricted stock awards granted to employees	Weighted Average Award-Date Shares Fair Value Unvested shares at January 3, 2015 1,590,000 $ 1.18 Granted - - Vested (510,000 ) 1.41 Forfeited - - Unvested shares at July 4, 2015 1,080,000 $ 1.08 Expected to Vest as of July 4, 2015 1,080,000 $ 1.08
Non-Employee stock options	Weighted Average Remaining Aggregate Number of Exercise Contractual Intrinsic Shares Price Term Value Outstanding at January 3, 2015 1,050,451 $ 1.35 5.46 Options Granted - - Options Classification from Employee to Non-Employee 1,202,762 0.91 Options Exercised - - Options Forfeited - - Outstanding at July 4, 2015 2,253,213 $ 1.12 6.28 $ 473,000 Exercisable at July 4, 2015 2,196,963 $ 1.11 6.21 $ 473,000
Restricted stock awards granted to non-employees	Weighted Average Shares Fair Value Unvested shares at January 3, 2015 76,000 $ 0.90 Granted 140,000 0.86 Vested (152,000 ) 1.21 Forfeited - - Unvested shares expected to vest at July 4, 2015 64,000 $ 1.22

Business Segments (Tables)

Business Segments (Tables)	6 Months Ended
	Jul. 04, 2015
Business Segments Tables
Business Segmentation	Three months ended July 4, 2015 Ingredients segment Core Standards and Contract Services segment Scientific and Regulatory Consulting segment Other Total Net sales $ 3,411,636 $ 2,371,477 $ 318,267 $ - $ 6,101,380 Cost of sales 1,869,205 1,635,294 126,189 - 3,630,688 Gross profit 1,542,431 736,183 192,078 - 2,470,692 Operating expenses: Sales and marketing 298,281 336,392 5,075 - 639,748 General and administrative - - - 2,015,004 2,015,004 Operating expenses 298,281 336,392 5,075 2,015,004 2,654,752 Operating income (loss) $ 1,244,150 $ 399,791 $ 187,003 $ (2,015,004 ) $ (184,060 ) Three months ended June 28, 2014 Ingredients segment Core Standards and Contract Services segment Scientific and Regulatory Consulting segment Other Total Net sales $ 1,721,872 $ 1,856,950 $ 277,332 $ - $ 3,856,154 Cost of sales 1,043,538 1,295,530 118,320 - 2,457,388 Gross profit 678,334 561,420 159,012 - 1,398,766 Operating expenses: Sales and marketing 310,386 221,797 39,365 - 571,548 General and administrative - - - 2,468,646 2,468,646 Operating expenses 310,386 221,797 39,365 2,468,646 3,040,194 Operating income (loss) $ 367,948 $ 339,623 $ 119,647 $ (2,468,646 ) $ (1,641,428 ) Six months ended July 4, 2015 Ingredients segment Core Standards and Contract Services segment Scientific and Regulatory Consulting segment Other Total Net sales $ 6,091,977 $ 4,671,520 $ 598,854 $ - $ 11,362,351 Cost of sales 3,472,381 3,209,078 282,576 - 6,964,035 Gross profit 2,619,596 1,462,442 316,278 - 4,398,316 Operating expenses: Sales and marketing 572,905 647,336 5,284 - 1,225,525 General and administrative - - - 4,262,935 4,262,935 Operating expenses 572,905 647,336 5,284 4,262,935 5,488,460 Operating income (loss) $ 2,046,691 $ 815,106 $ 310,994 $ (4,262,935 ) $ (1,090,144 ) Six months ended June 28, 2014 Ingredients segment Core Standards and Contract Services segment Scientific and Regulatory Consulting segment Other Total Net sales $ 2,858,181 $ 3,592,833 $ 479,278 $ - $ 6,930,292 Cost of sales 1,761,715 2,489,165 295,638 - 4,546,518 Gross profit 1,096,466 1,103,668 183,640 - 2,383,774 Operating expenses: Sales and marketing 550,346 434,572 51,197 - 1,036,115 General and administrative - - - 4,806,309 4,806,309 Loss from investment in affiliate - - - 21,543 21,543 Operating expenses 550,346 434,572 51,197 4,827,852 5,863,967 Operating income (loss) $ 546,120 $ 669,096 $ 132,443 $ (4,827,852 ) $ (3,480,193 ) -13- Core Standards and Scientific and At July 4, 2015 Ingredients Contract Services Regulatory Consulting segment segment segment Other Total Total assets $ 4,275,827 $ 3,406,936 $ 185,357 $ 6,354,474 $ 14,222,594 Core Standards and Scientific and At January 3, 2015 Ingredients Contract Services Regulatory Consulting segment segment segment Other Total Total assets $ 3,757,073 $ 3,220,518 $ 105,711 $ 4,433,545 $ 11,516,847

Nature of Business and Liquid25

Nature of Business and Liquidity (Details Narrative) - USD ($)	3 Months Ended			6 Months Ended
	Jul. 04, 2015	Apr. 04, 2015	Jun. 28, 2014	Jul. 04, 2015	Jun. 28, 2014	Jan. 03, 2015
Liquidity
Operating (loss)	$ (184,060)		$ (1,641,428)	$ (1,090,144)	$ (3,480,193)
Net (loss)	(315,192)	$ (1,025,515)	(1,653,142)	(1,340,707)	(3,501,158)
Cash and cash equivalents	$ 5,699,248		$ 1,280,627	$ 5,699,248	$ 1,280,627	$ 3,964,750

Significant Accounting Polici26

Significant Accounting Policies (Details) - USD ($)	Jul. 04, 2015	Apr. 04, 2015	Jan. 03, 2015
Assets
Current assets	$ 12,314,764		$ 9,898,691
Leasehold Improvements and Equipment, net	1,552,250		1,264,660
Other noncurrent assets			353,496
Total assets	14,222,594		11,516,847
Liabilities and Stockholders' Equity
Current liabilities	5,032,147		4,980,820
Loan payable, less current maturities, net	4,629,023		1,977,113
Capital lease obligations, less current maturities	556,029		423,015
Deferred rent, less current	108,933		137,508
Total liabilities	10,326,132		7,518,456
Total stockholders' equity	3,896,462	$ 3,688,785	3,998,391
Total liabilities and stockholders' equity	$ 14,222,594		11,516,847
Scenario, Previously Reported [Member]
Assets
Current assets			9,898,691
Leasehold Improvements and Equipment, net			1,264,660
Other noncurrent assets			444,857
Total assets			11,608,208
Liabilities and Stockholders' Equity
Current liabilities			4,980,820
Loan payable, less current maturities, net			2,068,474
Capital lease obligations, less current maturities			423,015
Deferred rent, less current			137,508
Total liabilities			7,609,817
Total stockholders' equity			3,998,391
Total liabilities and stockholders' equity			$ 11,608,208
Restatement Adjustment [Member]
Assets
Current assets
Leasehold Improvements and Equipment, net
Other noncurrent assets			$ (91,361)
Total assets			$ (91,361)
Liabilities and Stockholders' Equity
Current liabilities
Loan payable, less current maturities, net			$ (91,361)
Capital lease obligations, less current maturities
Deferred rent, less current
Total liabilities			$ (91,361)
Total stockholders' equity
Total liabilities and stockholders' equity			$ (91,361)

Significant Accounting Polici27

Significant Accounting Policies (Details 1) - USD ($)	Jul. 04, 2015	Jan. 03, 2015
Inventories
Natural product fine chemicals	$ 1,695,315	$ 1,760,305
Bulk ingredients	1,957,718	2,298,036
Inventory-gross	3,653,033	4,058,341
Less valuation allowance	564,000	324,000
Inventory-net	$ 3,089,033	$ 3,734,341

Significant Accounting Polici28

Significant Accounting Policies (Details Narrative) - USD ($)	Jul. 04, 2015	Jan. 03, 2015
Significant Accounting Policies Details Narrative
Unamortized debt issuance costs	$ 85,161	$ 91,361

Loss Per Share Applicable to 29

Loss Per Share Applicable to Common Stockholders (Details) - USD ($)		3 Months Ended				6 Months Ended
		Jul. 04, 2015	Apr. 04, 2015	Jun. 28, 2014	Jun. 28, 2014	Jul. 04, 2015	Jun. 28, 2014
Net loss		$ (315,192)	$ (1,025,515)	$ (1,653,142)		$ (1,340,707)	$ (3,501,158)
Earnings per share
Basic and diluted loss per common share		$ 0		$ (0.02)		$ (.01)	$ (.03)
Weighted average common shares outstanding	[1]	107,409,894		106,185,584		107,304,245	106,130,972
Stock Option [Member]
Earnings per share
Potentially dilutive securities	[2]	14,120,114			14,686,002	14,120,114	14,686,002
Warrant [Member]
Earnings per share
Potentially dilutive securities	[2]	469,020				469,020
Convertible Debt [Member]
Earnings per share
Potentially dilutive securities	[2]	773,395				773,395
[1]	Includes 1,230,484 and 1,600,879 weighted average nonvested shares of restricted stock for the three months ended July 4, 2015 and June 28, 2014, respectively, and 1,392,285 and 1,571,483 weighted average nonvested shares of restricted stock for the six months ended July 4, 2015 and June 28, 2014, respectively, which are participating securities.
[2]	Excluded from the computation of loss per share as their impact is antidilutive.

Loss Per Share Applicable to 30

Loss Per Share Applicable to Common Stockholders (Details Narrative) - shares	3 Months Ended		6 Months Ended
	Jul. 04, 2015	Jun. 28, 2014	Jul. 04, 2015	Jun. 28, 2014
Loss Per Share Applicable To Common Stockholders Details Narrative
Weighted average nonvested shares of restricted stock	1,230,484	1,600,879	1,392,285	1,571,483

Leasehold Improvements and Eq31

Leasehold Improvements and Equipment (Details) - USD ($)	Jul. 04, 2015	Jan. 03, 2015
Leasehold improvements and equipment
Laboratory equipment	$ 3,530,714	$ 3,151,748
Leasehold improvements	503,343	495,240
Computer equipment	347,786	329,737
Furniture and fixtures	13,039	13,039
Office equipment	21,547	7,877
Construction in progress	18,948	68,141
Leasehold improvements and equipment, gross	4,435,377	4,065,782
Less accumulated depreciation	2,883,127	2,801,122
Leasehold improvements and equipment, total	$ 1,552,250	$ 1,264,660

Leasehold Improvements and Eq32

Leasehold Improvements and Equipment (Details Narrative) - USD ($)	6 Months Ended
	Jul. 04, 2015	Jun. 28, 2014
Leasehold Improvements And Equipment Details Narrative
Depreciation expense on leasehold improvements and equipment	$ 137,279	$ 106,832

Loan Payable - Loan payable (De

Loan Payable - Loan payable (Details) - USD ($)	Jul. 04, 2015	Jan. 03, 2015
Principal amount payable for following years ending December
2,015
2,016	$ 905,393
2,017	1,945,650
2,018	2,148,957
Total principal payments	5,000,000
Accrued end of term charge	31,410
Total loan payable	5,031,410
Less unamortized debt issuance costs and debt discount	253,796
Less current portion	148,591	$ 223,358
Loan payable – long term	$ 4,629,023	$ 1,977,113

Loan Payable (Details Narrative

Loan Payable (Details Narrative) - Jul. 04, 2015 - USD ($)	Total	Total
Debt Disclosure [Abstract]
Interest expenses	$ 115,000	$ 221,000
Term loan	5,000,000	5,000,000
Funded at closing	2,500,000	2,500,000
Remaining available	2,500,000	$ 2,500,000
Maturity date		Apr. 1, 2018
Interest-only period extended to		Mar. 31, 2016
Interest-only period extended to if revenue milestone hit		Jun. 30, 2016
Facility fee		$ 15,000
End of term charge	$ 93,750	$ 93,750
End of term charge rate		3.75%
Revenue milestone		Pursuant to the Amendment, the parties agreed that the interest only period shall be extended to March 31, 2016, provided however that if the Company’s consolidated revenue is equal to or greater than $11.5 million for the six months ending December 31, 2015, then the interest-only period shall be extended to June 30, 2016.

Share-Based Compensation - Empl

Share-Based Compensation - Employees Service Based (Details) - 6 months ended Jul. 04, 2015 - USD ($)	Total
Number of Shares
Outstanding at Beginning of Period	12,723,601
Options Granted	225,000
Options Classification from Employee to Non-Employee	$ (1,202,762)
Options Exercised	(22,745)
Options Forfeited	(56,193)
Outstanding at End of Period	11,666,901
Exercisable at End of Period	9,508,077
Weighted Average Exercise Price
Outstanding at Beginning of Period	$ 1.13
Options Granted	1.28
Options Classification from Employee to Non-Employee	.91
Options Exercised	.69
Options Forfeited	1.18
Outstanding at End of Period	1.16
Exercisable at End of Period	$ 1.16
Weighted Average Remaining Contractual Term
Outstanding at Beginning of Period	7 years
Options Granted	10 years
Outstanding at End of Period	6 years 5 months 15 days
Exercisable at End of Period	6 years 9 days
Aggregate Intrinsic Value
Outstanding at End of Period	$ 2,231,000
Exercisable at End of Period	$ 1,862,000

Share-Based Compensation - Assu

Share-Based Compensation - Assumptions (Details 1) - 6 months ended Jul. 04, 2015	Total
Weighted average assumptions for options granted to employees
Expected volatility	75.00%
Expected dividends	0.00%
Expected term	6 years
Risk-free rate	1.72%

Share-Based Compensation - Em37

Share-Based Compensation - Employees - Restricted Stock (Details 2) - 6 months ended Jul. 04, 2015 - Restricted Stock [Member] - $ / shares	Total
Summary of activity of restricted stock awards granted to employees- Shares
Unvested shares at Beginning of Period	1,590,000
Granted
Vested	(510,000)
Forfeited
Unvested shares at End of Period	1,080,000
Expected to Vest as of End of Period	1,080,000
Weighted Average Award-Date Fair Value
Unvested shares at Beginning of Period	$ 1.18
Granted
Vested	$ 1.41
Forfeited
Unvested shares at End of Period	$ 1.08
Expected to Vest as of End of Period	$ 1.08

Share-Based Compensation - NonE

Share-Based Compensation - NonEmployee (Details 3) - Jul. 04, 2015 - USD ($)	Total
Non-Employee Share-Based Compensation- Options
Outstanding at Beginning of Period	1,050,451
Options Granted
Options Classification from Employee to Non-Employee	1,202,762
Options Exercised
Options Forfeited
Outstanding at End of Period	2,253,213
Exercisable at End of Period	2,196,963
Weighted Average Exercise Price
Outstanding at Beginning of Period	$ 1.35
Options Granted
Options Classification from Employee to Non-Employee	$ .91
Options Exercised
Options Forfeited
Outstanding at End of Period	$ 1.12
Exercisable at End of Period	$ 1.11
Weighted Average Remaining Contractual Term
Outstanding at Beginning of Period	5 years 5 months 15 days
Outstanding at End of Period	6 years 3 months 11 days
Exercisable at End of Period	5 years 2 months 15 days
Aggregate Intrinsic Value
Outstanding at End of Period	$ 473,000
Exercisable at End of Period	$ 473,000

Share-Based Compensation - Rest

Share-Based Compensation - Restricted Stock (Details 4) - 6 months ended Jul. 04, 2015 - NonEmployee Restricted Stock [Member] - $ / shares	Total
Unvested shares at Beginning of Period	76,000
Granted	140,000
Vested	(152,000)
Forfeited
Unvested shares expected to vest at End of Period	64,000
Weighted Average Award-Date Fair Value
Unvested shares at Beginning of Period	$ 0.90
Granted	.86
Vested	$ 1.21
Forfeited
Unvested shares at End of Period	$ 1.22

Share-Based Compensation (Detai

Share-Based Compensation (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	Jul. 04, 2015	Jun. 28, 2014	Jul. 04, 2015	Jun. 28, 2014
Options issued
Brauser [Member]
Shares vested			250,000
Honig [Member]
Shares vested			250,000
Germain [Member]
Shares vested			10,000
Employee Comp [Member]
Weighted average fair value of options granted			$ .85
Closing stock price	$ 1.22		$ 1.22
Unrecognized stock option expense	$ 1,173,000		$ 1,173,000
Period of stock option expense expected to be recognized over			2 years 5 months 12 days
General and administrative expenses	$ 442,000	$ 1,021,000	$ 820,000	$ 1,970,000
Employee Comp [Member] | Former Director [Member]
Common stock shares awarded, shares	125,000
Fair value of stock award	$ 154,000
NonEmployee Comp [Member]
Closing stock price	$ 1.22		$ 1.22
Unrecognized stock option expense	$ 38,000		$ 38,000
Period of stock option expense expected to be recognized over			1 year 2 months 8 days
General and administrative expenses	$ 65,000	$ 16,000	$ 403,000	$ 66,000
Common stock shares awarded, shares			350,000
Common stock shares awarded fully vested, shares	210,000		210,000
Common stock shares awarded, period of expense to be recognized			2 months
Unrecognized expense related to restricted stock awards	$ 78,000		$ 78,000
Restricted Stock award, period of expense expected to be recognized over			2 years 8 months 12 days
Fair value of vested restricted stock awards			$ 15,000
Shares vested			140,000

Business Segments (Details)

Business Segments (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jul. 04, 2015	Jun. 28, 2014	Jul. 04, 2015	Jun. 28, 2014
Business Segmentation
Net sales	$ 6,101,380	$ 3,856,154	$ 11,362,351	$ 6,930,292
Cost of sales	3,630,688	2,457,388	6,964,035	4,546,518
Gross profit	2,470,692	1,398,766	4,398,316	2,383,774
Operating expenses:
Sales and marketing	639,748	571,548	1,225,525	1,036,115
General and administrative	2,015,004	2,468,646	4,262,935	4,806,309
Loss from investment in affiliate				21,543
Operating expenses	2,654,752	3,040,194	5,488,460	5,863,967
Operating income (loss)	(184,060)	(1,641,428)	(1,090,144)	(3,480,193)
Assets	14,222,594		14,222,594
Ingredients Segment [Member]
Business Segmentation
Net sales	3,411,636	1,721,872	6,091,977	2,858,181
Cost of sales	1,869,205	1,043,538	3,472,381	1,761,715
Gross profit	1,542,431	678,334	2,619,596	1,096,466
Operating expenses:
Sales and marketing	$ 298,281	$ 310,386	$ 572,905	$ 550,346
General and administrative
Loss from investment in affiliate
Operating expenses	$ 298,281	$ 310,386	$ 572,905	$ 550,346
Operating income (loss)	1,244,150	367,948	2,046,691	546,120
Assets	4,275,827		4,275,827
CoreStandardsContractServices [Member]
Business Segmentation
Net sales	2,371,477	1,856,950	4,671,520	3,592,833
Cost of sales	1,635,294	1,295,530	3,209,078	2,489,165
Gross profit	736,183	561,420	1,462,442	1,103,668
Operating expenses:
Sales and marketing	$ 336,392	$ 221,797	$ 647,336	$ 434,572
General and administrative
Loss from investment in affiliate
Operating expenses	$ 336,392	$ 221,797	$ 647,336	$ 434,572
Operating income (loss)	399,791	339,623	815,106	669,096
Assets	3,406,936		3,406,936
Regulatory Consulting [Member]
Business Segmentation
Net sales	318,267	277,332	598,854	479,278
Cost of sales	126,189	118,320	282,576	295,638
Gross profit	192,078	159,012	316,278	183,640
Operating expenses:
Sales and marketing	$ 5,075	$ 39,365	$ 5,284	$ 51,197
General and administrative
Loss from investment in affiliate
Operating expenses	$ 5,075	$ 39,365	$ 5,284	$ 51,197
Operating income (loss)	187,003	$ 119,647	310,994	$ 132,443
Assets	$ 185,357		$ 185,357
Other Segment [Member]
Business Segmentation
Net sales
Cost of sales
Gross profit
Operating expenses:
Sales and marketing
General and administrative	$ 2,015,004	$ 2,468,646	$ 4,262,935	$ 4,806,309
Loss from investment in affiliate				21,543
Operating expenses	2,015,004	2,468,646	4,262,935	4,827,852
Operating income (loss)	(2,015,004)	$ (2,468,646)	(4,262,935)	$ (4,827,852)
Assets	$ 6,354,474		$ 6,354,474

Commitments and Contingencies (

Commitments and Contingencies (Details Narrative) - Jul. 04, 2015 - USD ($)	Total
Capital Lease Obligations [Member]
Monthly lease payment	$ 7,000
Capital lease term	48 months
Capital lease future payments	$ 356,000
Capital lease	304,000
Capital Lease Obligations 2 [Member]
Monthly lease payment	$ 5,000
Capital lease term	60 months
Capital lease future payments	$ 276,000
Capital lease	$ 243,000

Subsequent Events (Details Narr

Subsequent Events (Details Narrative) - $ / shares	1 Months Ended	6 Months Ended
	Aug. 13, 2015	Jul. 04, 2015
Share based compensation, exercise price per share
Director [Member]
Share based compensation, options, shares	675,000
Share based compensation, exercise price per share	$ 1.22
Employees [Member]
Share based compensation, options, shares	917,000
Share based compensation, exercise price per share	$ 1.22
Fried [Member]
Share based compensation, options, shares	200,000

Uncategorized Items - cdxc-2015

Label	Element	Value
CoreStandardsContractServices [Member]
Total assets	us-gaap_Assets	$ 3,220,518
Ingredients Segment [Member]
Total assets	us-gaap_Assets	3,757,073
Other Segment [Member]
Total assets	us-gaap_Assets	4,433,545
Regulatory Consulting [Member]
Total assets	us-gaap_Assets	$ 105,711